MedPacto, Inc. (235980.KQ)

KRW 4585.0

(-1.4%)

Revenue Summary of MedPacto, Inc.

MedPacto, Inc.'s latest annual revenue in 2023 was - KRW , down 0.0% from previous year.
MedPacto, Inc.'s latest quarterly revenue in 2024 Q2 was - KRW , down 0.0% from previous quarter.
MedPacto, Inc. reported a annual revenue of - KRW in annual revenue 2022, down 0.0% from previous year.
MedPacto, Inc. reported a annual revenue of - KRW in annual revenue 2021, down 0.0% from previous year.
MedPacto, Inc. reported a quarterly revenue of - KRW for 2024 Q1, down 0.0% from previous quarter.
MedPacto, Inc. reported a quarterly revenue of - KRW for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of MedPacto, Inc. (2023 - 2017)

Historical Annual Revenue of MedPacto, Inc. (2023 - 2017)

Year	Revenue	Revenue Growth
2023	- KRW	0.0%
2022	- KRW	0.0%
2021	- KRW	0.0%
2020	- KRW	0.0%
2019	- KRW	0.0%
2018	- KRW	0.0%
2017	- KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q2	- KRW	0.0%
2024 Q1	- KRW	0.0%
2023 Q4	- KRW	0.0%
2023 FY	- KRW	0.0%
2023 Q3	- KRW	0.0%
2023 Q2	- KRW	0.0%
2023 Q1	- KRW	0.0%
2022 Q2	- KRW	0.0%
2022 FY	- KRW	0.0%
2022 Q3	- KRW	0.0%
2022 Q4	- KRW	0.0%
2022 Q1	- KRW	0.0%
2021 Q1	- KRW	0.0%
2021 Q3	- KRW	0.0%
2021 Q2	- KRW	0.0%
2021 Q4	- KRW	0.0%
2021 FY	- KRW	0.0%
2020 Q3	- KRW	0.0%
2020 FY	- KRW	0.0%
2020 Q4	- KRW	0.0%
2019 FY	- KRW	0.0%
2018 FY	- KRW	0.0%
2017 FY	- KRW	0.0%

Peer Revenue Comparison of MedPacto, Inc.

Name	Revenue	Revenue Difference
HLB Co., Ltd.	42.9 Billion KRW	100.0%
iNtRON Biotechnology, Inc.	9.58 Billion KRW	100.0%
BINEX Co., Ltd.	154.82 Billion KRW	100.0%
Bioneer Corporation	263.23 Billion KRW	100.0%
Anterogen.Co.,Ltd.	6.5 Billion KRW	100.0%
MEDIPOST Co., Ltd.	68.64 Billion KRW	100.0%
CrystalGenomics, Inc.	4.87 Billion KRW	100.0%
Helixmith Co., Ltd	4.2 Billion KRW	100.0%
Chabiotech Co.,Ltd.	953.95 Billion KRW	100.0%
Medy-Tox Inc.	221.12 Billion KRW	100.0%
Peptron, Inc.	3.34 Billion KRW	100.0%
Amicogen, Inc.	159.9 Billion KRW	100.0%
Genexine, Inc.	4.42 Billion KRW	100.0%
HLB Therapeutics Co.,Ltd.	53.74 Billion KRW	100.0%
LegoChem Biosciences, Inc.	34.14 Billion KRW	100.0%
ALTEOGEN Inc.	96.52 Billion KRW	100.0%
PharmaResearch Co., Ltd.	261.01 Billion KRW	100.0%
SillaJen, Inc.	3.93 Billion KRW	100.0%
JETEMA, Co., Ltd.	58.71 Billion KRW	100.0%
OliX Pharmaceuticals,Inc	17.06 Billion KRW	100.0%
Genomictree Inc.	3.41 Billion KRW	100.0%
D&D Pharmatech	18.67 Billion KRW	100.0%
EASY BIO,Inc.	165.38 Billion KRW	100.0%
GI Innovation, Inc.	5.31 Billion KRW	100.0%